North American Molecular Diagnostics Market Size, Share, Growth Analysis, By Product(Instruments, Reagents), By Test Location(Point-of-Care (PoC), Self-test or Over the Counter (OTC), Central Laboratories), By Technology(Polymerase Chain Reaction (PCR), Multiplex PCR, Other PCR, In Situ Hybridization), By Application(Oncology, Breast Cancer, Prostate Cancer, Colorectal Cancer), By Regional(The U.S.) - Industry Forecast 2024-2031

North American Molecular Diagnostics Market Competitive Landscape

To understand the competitive landscape, we are analyzing key North American Molecular Diagnostics Market vendors in the market. To understand the competitive rivalry, we are comparing the revenue, expenses, resources, product portfolio, region coverage, market share, key initiatives, product launches, and any news related to the North American Molecular Diagnostics Market.

To validate our hypothesis and validate our findings on the market ecosystem, we are also conducting a detailed porter's five forces analysis. Competitive Rivalry, Supplier Power, Buyer Power, Threat of Substitution, and Threat of New Entry each force is analyzed by various parameters governing those forces.

Key Players Covered in the Report:

• Roche Diagnostics
• Qiagen N.V.
• Danaher
• Hologic, Inc.
• Johnson & Johnson
• Becton, Dickinson and Company
• Abbott laboratories
• bioMérieux SA
• Illumina, Inc.
• Novartis AG
• Cepheid, Inc.